|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1992-10-22
|
|
pubmed:abstractText |
A sensitive bioluminescent enzyme immunoassay (BEIA) for the determination of human alpha-atrial natriuretic peptide was developed. The usable ranges of the standard curve extend from 10 pg to 400 pg for the one-step method and from 2.5 to 50 pg for the two-step method.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0939-4974
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Bioluminescence enhanced enzyme immunoassay for human alpha-atrial natriuretic peptide using luciferin-luciferase.
|
|
pubmed:affiliation |
Laboratoire de Physiologie, UFR de Pharmacie, Limoges, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
